Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Nov 28, 2021. (Total: 43636 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 7304 Records)

Next

Query Trace: all[original query]>>Translation/Implementation Studies[Product Type]
A multi-task dual-stream attention network for the identification of KRAS mutation in colorectal cancer.
Song Kai et al. Medical physics 2021
Predictors of Population Awareness of Cancer Genetic Tests: Implications for Enhancing Equity in Engaging in Cancer Prevention and Precision Medicine.
Giri Veda N et al. JCO precision oncology 2021 5
Telephone versus in-person genetic counseling for hereditary cancer risk: Patient predictors of differential outcomes.
Binion Savannah et al. Journal of telemedicine and telecare 2021 1357633X211052220
Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma.
Zhao Hong-Yue et al. Neoplasma 2021
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.
de Andrade Kelvin César et al. The Lancet. Oncology 2021
Genome-wide identification and characterization of circular RNA mA modification in pancreatic cancer.
Ye Ying et al. Genome medicine 2021 13(1) 183
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC.
Qiu Bin et al. Nature communications 2021 12(1) 6770
Parental age and retinoblastoma-a retrospective study of demographic data and genetic analysis.
Tanwar Meghana et al. Eye (London, England) 2021
Germline cancer susceptibility gene testing in unselected patients with hepatobiliary cancers: A multi-center prospective study.
Uson Junior Pedro Ls et al. Cancer prevention research (Philadelphia, Pa.) 2021
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Jank Paul et al. Breast cancer research and treatment 2021
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Page Ray D et al. Clinical lung cancer 2021
Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases.
De Marchi Pedro et al. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 1-6
Concordance of BRCA mutation detection in tumor versus blood, and frequency of bi-allelic loss of BRCA in tumors from patients in the phase III SOLO2 trial.
Hodgson Darren R et al. Gynecologic oncology 2021
Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience.
Devereaux Kelly A et al. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021
Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants.
Douglas Michael P et al. Journal of community genetics 2021
Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer.
Obón-Santacana Mireia et al. BMC medicine 2021 19(1) 261
The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study.
Fjaellegaard Katrine et al. European clinical respiratory journal 2021 8(1) 1984375
Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy.
Takeda Takashi et al. Japanese journal of clinical oncology 2021
TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
Yabe Mariko et al. Cancers 2021 13(21)
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).
Folprecht Gunnar et al. Clinical colorectal cancer 2021
Integrating NGS-derived mutational profiling in the diagnosis of multiple lung adenocarcinomas.
Ezer Nicole et al. Cancer treatment and research communications 2021 29100484
Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti Christopher M et al. JAMA network open 2021 4(11) e2133205
Constructing germline research cohorts from the discarded reads of clinical tumor sequences.
Gusev Alexander et al. Genome medicine 2021 13(1) 179
Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.
Gargallo Pablo et al. Cancers 2021 13(21)
Clinical Value of NGS Genomic Studies for Clinical Management of Pediatric and Young Adult Bone Sarcomas.
Gutiérrez-Jimeno Miriam et al. Cancers 2021 13(21)
Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
Stempa Klaudia et al. Cancers 2021 13(21)
Factors Affecting Time to Surgery in Breast Cancer Patients.
Chagpar Anees B et al. The American surgeon 2021 31348211054714
Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size.
Dublin Jared C et al. JAMA otolaryngology-- head & neck surgery 2021
Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits.
Nazareth Shivani et al. Obstetrics and gynecology 2021
The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance.
Grandi Giovanni et al. Menopause (New York, N.Y.) 2021
TOP